发明名称 Sulfonamide compounds and uses as TNAP inhibitors
摘要 Described herein are compounds that modulate the activity of TNAP. In some embodiments, the compounds described herein inhibit TNAP. In certain embodiments, the compounds described herein are useful in the treatment of conditions associated with hyper-mineralization.
申请公布号 US9458147(B2) 申请公布日期 2016.10.04
申请号 US201314379475 申请日期 2013.02.21
申请人 SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 发明人 Pinkerton Anthony B.;Dahl Russell;Cosford Nicholas D. P.;Millan Jose Luis
分类号 C07D213/76;C07D215/38;C07D409/04;C07D405/04;C07D409/12;C07D417/04;C07D405/12;C07D401/12;C07D401/04;A61K31/44;A61K31/50;C07D213/80;C07D213/82;C07D231/42;C07D333/36;C07D237/20;C07D239/69;C07D241/22;C07D261/16;C07D263/50;C07D271/113;C07D277/52;C07D285/135 主分类号 C07D213/76
代理机构 Wilson, Sonsini, Goodrich & Rosati 代理人 Wilson, Sonsini, Goodrich & Rosati
主权项 1. A compound of Formula I, or a pharmaceutically acceptable salt, polymorph, solvate, tautomer, or N-oxide thereof:wherein: Y1 is a bond, and Y2 is —N(R6)—; L1 and L2 are each a bond; X1 is ═N— or ═C(R2)—; X2 is ═N— or ═C(R3)—; R1 and R4 are independently selected from the group consisting of —F, —Cl, —Br, —CN, —C(O)—N(R7)—R8, —C(O)—O—R9, —OMe, —OCF3, optionally substituted phenyl, and optionally substituted 5- or 6-membered heteroaryl; R2, R3, and R5 are hydrogen; R6 is hydrogen; R7 and R8 are independently hydrogen, optionally substituted alkyl, haloalkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted phenyl, or R7 and R8 together with the nitrogen atom to which they are attached form an optionally substituted heterocycloamino; R9 is selected from the group consisting of hydrogen, optionally substituted alkyl, haloalkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, and optionally substituted phenyl; and A is —C(O)—N(R7)—R8, or —C(O)—O—R9, or A is an optionally substituted phenyl or optionally substituted 5- or 6-membered heteroaryl, wherein A is selected from: R12 and R13 are independently selected from the group consisting of hydrogen, halogen, —CN, —OH, —C(O)—O—R19, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted alkoxy, haloalkyl, haloalkoxy, optionally substituted phenyl, and optionally substituted 5- or 6-membered heteroaryl; R19 is selected from the group consisting of hydrogen, optionally substituted alkyl, haloalkyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, and optionally substituted phenyl; and R15 is hydrogen or optionally substituted alkyl.
地址 La Jolla CA US
您可能感兴趣的专利